Cargando…

Sex difference in atrial fibrillation recurrence after catheter ablation and antiarrhythmic drugs

OBJECTIVE: The risk of recurrence after atrial fibrillation (AF) catheter ablation (AFCA) is higher in women than in men. However, it is unknown whether a sex difference exists in antiarrhythmic drug (AAD) responsiveness among patients with recurrence. METHODS: Among 2999 consecutive patients (26.5%...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Yoon Jung, Park, Je-Wook, Yu, Hee Tae, Kim, Tae-Hoon, Uhm, Jae-Sun, Joung, Boyoung, Lee, Moon-Hyoung, Pak, Hui-Nam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Arrhythmias and Sudden Death
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086497/ https://www.ncbi.nlm.nih.gov/pubmed/35332048 http://dx.doi.org/10.1136/heartjnl-2021-320601

Ejemplares similares

Catheter ablation for the management of atrial fibrillation: current technical perspectives
por: Hong, Kathryn Lauren, et al.
Publicado: (2020)

Characterising symptom clusters in patients with atrial fibrillation undergoing catheter ablation
por: Hobensack, Mollie, et al.
Publicado: (2023)

Left atrial strain predicts recurrence of atrial arrhythmias after catheter ablation of persistent atrial fibrillation
por: Parwani, Abdul Shokor, et al.
Publicado: (2017)

Changes in quality of life, cognition and functional status following catheter ablation of atrial fibrillation
por: Piccini, Jonathan P, et al.
Publicado: (2020)

Effect of catheter ablation on quality of life in patients with atrial fibrillation and its correlation with arrhythmia outcome
por: Raine, Daniel, et al.
Publicado: (2015)

Incremental predictive value of left atrial strain and left atrial appendage function in rhythm outcome of non-valvular atrial fibrillation patients after catheter ablation
por: Ma, Xin-Xin, et al.
Publicado: (2021)

Safety and efficacy of dabigatran versus warfarin in patients undergoing catheter ablation of atrial fibrillation: a systematic review and meta-analysis
por: Providência, Rui, et al.
Publicado: (2014)

Impact of COVID-19 on patients awaiting ablation for atrial fibrillation
por: Pius, Charlene, et al.
Publicado: (2022)

Quality of life and healthcare utilisation improvements after atrial fibrillation ablation
por: Gupta, Dhiraj, et al.
Publicado: (2021)

Adjunctive interpulmonary isthmus ablation has no added effects on atrial fibrillation recurrence
por: Higashiya, Shunichi, et al.
Publicado: (2017)

Atrioesophageal fistula following ablation procedures for atrial fibrillation: systematic review of case reports
por: Chavez, Patricia, et al.
Publicado: (2015)

Reducing radiation exposure during atrial fibrillation ablation using lectures to promote awareness
por: Miwa, Yosuke, et al.
Publicado: (2019)

Internationally validated score to predict the outcome of non-paroxysmal atrial fibrillation ablation: the ‘FLAME score’
por: Boyalla, Vennela, et al.
Publicado: (2021)

Prevalence and determinants of atrial fibrillation progression in paroxysmal atrial fibrillation
por: Nguyen, Bao-Oanh, et al.
Publicado: (2023)

Long-term outcomes after ablation of persistent atrial fibrillation: an observational study over 6 years
por: Wynn, Gareth J, et al.
Publicado: (2016)

Increased baseline ECG R-R dispersion predicts improvement in systolic function after atrial fibrillation ablation
por: Koene, Ryan J, et al.
Publicado: (2019)

Brady- and tachyarrhythmias detected by continuous rhythm monitoring in paroxysmal atrial fibrillation
por: Frausing, Maria Hee Jung Park, et al.
Publicado: (2023)

Disease understanding in patients newly diagnosed with atrial fibrillation
por: Kaufman, Brystana G, et al.
Publicado: (2018)

High incidence of atrial fibrillation in patients treated with ibrutinib
por: Baptiste, Florian, et al.
Publicado: (2019)

Inflammatory proteomics profiling for prediction of incident atrial fibrillation
por: Börschel, Christin S, et al.
Publicado: (2023)

Heart rate is associated with progression of atrial fibrillation, independent of rhythm
por: Holmqvist, Fredrik, et al.
Publicado: (2015)

Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation
por: Christersson, Christina, et al.
Publicado: (2019)

Association of income and health-related quality of life in atrial fibrillation
por: Guhl, Emily, et al.
Publicado: (2019)

Heart rate and adverse outcomes in patients with prevalent atrial fibrillation
por: Moschovitis, Giorgio, et al.
Publicado: (2021)

Prevalence and incidence rates of atrial fibrillation in Norway 2004–2014
por: Kjerpeseth, Lars Jøran, et al.
Publicado: (2021)

Discontinuation of oral anticoagulation in atrial fibrillation and risk of ischaemic stroke
por: García Rodríguez, Luis Alberto, et al.
Publicado: (2021)

Effectiveness and safety of oral anticoagulants in elderly patients with atrial fibrillation
por: Rutherford, Ole-Christian Walter, et al.
Publicado: (2022)

Sex differences of vascular brain lesions in patients with atrial fibrillation
por: Ceylan, Selinda, et al.
Publicado: (2022)

Comprehensive nationwide incidence and prevalence trends of atrial fibrillation in Finland
por: Lehto, Mika, et al.
Publicado: (2022)

Long-term risk of atrial fibrillation after the death of a partner
por: Graff, Simon, et al.
Publicado: (2016)

Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation
por: Camm, A John, et al.
Publicado: (2017)

Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation
por: Bahit, M Cecilia, et al.
Publicado: (2017)

Modifiable risk factors predict incident atrial fibrillation and heart failure
por: Wong, Jorge A, et al.
Publicado: (2020)

Prognostic significance of patent foramen ovale in anticoagulated patients with atrial fibrillation
por: Melduni, Rowlens M, et al.
Publicado: (2020)

Eligibility for early rhythm control in patients with atrial fibrillation in the UK Biobank
por: Kany, Shinwan, et al.
Publicado: (2022)

Cardiovascular and renal multimorbidity increase risk of atrial fibrillation in the PREVEND cohort
por: Van Deutekom, Colinda, et al.
Publicado: (2023)

Development and validation of prediction models for incident atrial fibrillation in heart failure
por: Vinter, Nicklas, et al.
Publicado: (2023)

Future Innovations in Novel Detection for Atrial Fibrillation (FIND-AF): pilot study of an electronic health record machine learning algorithm-guided intervention to identify undiagnosed atrial fibrillation
por: Nadarajah, Ramesh, et al.
Publicado: (2023)

Systematic review of the incidence and clinical risk predictors of atrial fibrillation and permanent pacemaker implantation for bradycardia in Fabry disease
por: Vijapurapu, Ravi, et al.
Publicado: (2023)

Proposed A(2)C(2)S(2)-VASc score for predicting atrial fibrillation development in patients with atrial flutter
por: Chen, Yung-Lung, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e5jvthlcaite84eig1umq2ivot